24/7 Market News Snapshot 02 June, 2025 – Nutriband Inc. Common Stock (NASDAQ:NTRB)
DENVER, Colo., 02 June, 2025 (www.247marketnews.com) – (NASDAQ:NTRB) are discussed in this article.
Nutriband Inc. (NASDAQ:NTRB) is experiencing significant momentum in the market, marked by a notable increase in its stock price, which opened at $8.20 and has surged to approximately $7.96, reflecting an impressive 22.51% rise from the previous close of $6.50. With a trading volume of 510.97K shares, this robust activity indicates strong investor interest and a potential bullish trend for the company.
In addition to its positive market performance, Nutriband has announced record revenue figures for the first quarter ending April 30, 2025, generating $667,000, which represents a 63% increase year-over-year. This growth can be attributed to strategic production ramps at its Pocono Pharma subsidiary, which has adopted penetration pricing strategies to capture market share and establish partnerships with leading retailers across the nation. This strategic approach not only enhances product accessibility for consumers but also supports the company’s long-term commitment to maximizing shareholder value.
Furthermore, Nutriband is making strides in the pharmaceutical sector with the development of its AVERSA Fentanyl patch, a product that has garnered attention for its potential to serve as the world’s first abuse-deterrent opioid patch. The company has secured a partnership with Kindeva Drug Delivery to share development costs in exchange for substantial milestone payments. This collaboration aims to advance Nutriband’s innovative transdermal drug delivery solutions toward regulatory approval, with projected annual sales for the AVERSA patch estimated between $80 million and $200 million in the U.S.
Nutriband’s strategic initiatives in product development and market expansion reflect its commitment to enhancing patient safety and care while fostering extensive growth opportunities in the evolving pharmaceutical landscape.
Related news for (NTRB)
- FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
- 24/7 Market News Snapshot 08 August, 2025 – Nutriband Inc. Common Stock (NASDAQ:NTRB)
- Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval
- 24/7 Market News Snapshot 02 July, 2025 – Nutriband Inc. Common Stock (NASDAQ:NTRB)
- Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch